BioMedWire Stocks Archives - Page 3 of 83

TuesdayAug 25, 2026 10:00 am

Personalized mRNA Vaccine Prevents Melanoma Recurrence, New Study Finds

A new study whose results are yet to be peer-reviewed has shown that a personalized mRNA vaccine made from the tumor tissue of a patient can prevent the cancer from recurring years after the treatment is given. The study was a joint undertaking by pharmaceutical firms Merck and Moderna. The clinical trial involved giving more than 1,000 patients a combination of an immunotherapy medication called Keytruda after a surgical procedure to remove melanoma, a deadly type of skin cancer. Patients also received Intismeran, a personalized cancer vaccine. The personalized vaccine was produced by extracting tumor samples and formulating the mRNA vaccine for each participant. …

FridayAug 21, 2026 10:00 am

Researchers Test Simple Fix That Saves Time Spent in ERs

A new study has confirmed that a simple fix in the way patients are treated in emergency rooms (ERs) can speed up care and reduce the amount of time patients wait before being attended to. The fix involves treating selected patients while they are seated instead of waiting for an ER bed to become available so they can be attended to. The study, whose findings appeared in the journal Management Science, sought to find a way to speed up patient care without compromising the quality of care delivered. The researchers started their work by looking at the biggest bottleneck ERs face: the lack of enough beds at these medical facilities. They observed that beds are in short supply and…

ThursdayAug 20, 2026 10:00 am

Former Adviser to Fauci Pleads Guilty to Covid-Related Conspiracy Charge

Dr. David Morens, formerly an adviser to Anthony Fauci during the Covid-19 pandemic, has pleaded guilty to a charge of conspiracy to conceal information about the pandemic. The charge focuses on attempts to conceal documents of the government by evading laws that allow members of the public to access records in the possession of the government. The particulars of the charge brought against Morens in a Maryland federal court indicate that he undertook to conceal information about a research grant to a Chinese entity that had been identified as a possible origin of the pandemic. Morens, aged 78, was indicted in April this year after prosecutors…

FridayAug 14, 2026 10:00 am

Little-Known Immune Cells Bolster Anticancer Fight, Study Finds

Researchers from the University of Manchester in the UK have found that a small group of immune cells that aren’t given much attention by scientists is actually crucial in mobilizing the immune system to attack and sustain its fight against cancer. The study, whose findings appeared in the journal Immunity, explored what impact the activation or deactivation of these particular immune cells would have on the body’s response to cancer. For their study, the team designed mouse models in which it was possible to label or actually remove activated dendritic cells. Until this particular study was undertaken, it was hard for the research community to study the role of these cells during the…

ThursdayAug 13, 2026 10:00 am

Global Drugmakers Earmark Billions to Ramp Up Their US Footprint

Dozens of global drugmakers are ramping up their investments in the United States in a bid to sidestep the planned tariffs on drug imports. In total, ongoing investments and planned expansions amount to approximately $500 billion. These planned investments are intended to not only reassure investors but also mitigate risks linked to global supply chains, such as the evolving tariff environment. Last September, Pfizer engaged in discussions with Trump, and the drugmaker undertook to invest about $70 billion in domestic R&D as well as manufacturing. In exchange, Trump granted the company an exemption of three years from any tariffs that are imposed on drug imports into…

FridayAug 07, 2026 10:00 am

Spanish Patient Highlights Risks of Poorly Cooked Pork

Doctors in Spain recently handled a fascinating yet terrifying case of a patient that developed brain cancer-like symptoms and was treated as such, but additional tests brought to light a scarier cause of his illness: cysts resulting from a pork tapeworm infection. This case highlights the dangers of exposure to these worms, or eating pork that hasn’t been cooked fully. The patient’s medical mystery started with worsening headaches that lasted more than two weeks. His behavior also started changing in subtle ways, and these symptoms prompted him to visit his doctor. A CT scan conducted on his brain showed he had lesions, and the doctor feared that he had cancer that…

ThursdayAug 06, 2026 10:00 am

Liquid Biopsy Forecasts Response to Immunotherapy in Lung Cancer Patients

While immunotherapy is revolutionizing cancer therapy, response rates to these novel treatments are low and some patients that initially respond well end up becoming unresponsive. Scientists have been working to develop tools that can help in predicting which patients are likely to benefit from immunotherapy, and a new liquid biopsy has provided a simpler way to do just that for patients with advanced lung cancer. According to a study that was published in the journal Clinical Cancer Research, a team at the Kimmel Cancer Research Center at Johns Hopkins together with their collaborators was able to develop a liquid biopsy that can accurately predict which patients will benefit from immunotherapy against…

FridayJul 31, 2026 10:00 am

Climate Change is Accelerating the Spread of Infectious Diseases, Experts Warn

Scientists and public health experts are warning that climate change is accelerating the rate at which infectious diseases spread, and policymakers don’t seem to be taking this threat as seriously as they should. A sobering example is the 14 million cases of dengue fever that were recorded globally in 2024. This figure was double what had been documented in 2023, 7 million cases. A major contributor to this spike was the El Niño weather that occurred around that time. That spike in dengue cases was alarming, and it was also a warning sign that as the planet continued warming up, many more such massive outbreaks of infectious diseases…

ThursdayJul 30, 2026 10:00 am

Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment

Glioblastoma multiforme (GBM) is the deadliest type of brain cancer and patients usually die within 15 months from the time they are diagnosed with the malignancy. Existing treatments like surgery, chemotherapy and radiotherapy aren’t effective in halting the progression of this disease. Now, a new study shows that an experimental therapy containing vitamin B12 could halt GBM in its tracks. The study was conducted by a team at the Taussig Cancer Center of the Cleveland Clinic Foundation together with Nitric Oxide Services LLC. The researchers investigated a vitamin B12 compound called NO-Cbl (nitrosylcobalamin). This modified type of vitamin B12 releases nitric oxide. The purpose of the preclinical study was to look into whether this compound could…

TuesdayJul 28, 2026 10:00 am

Researchers Plan to Investigate Role of Autoantibodies in Cancer Risk, Immune Response

For a long time, scientists have wondered why many individuals that have several risk factors linked to cancer development never develop the disease while some people without any of these risk factors go on to develop cancer. A team of researchers strongly thinks autoantibodies could provide major insights into why this happens, and they are planning to conduct studies aimed at understanding how autoantibodies influence the likelihood of cancer development, the progression of the disease, and how immune function is shaped in response to cancer development. The team, led by Doctor Laurent Casanova, has done extensive work on autoantibodies, immune proteins that bind to different molecules like the proteins found on viruses, bacteria and other pathogens. These…